Celularity (CELUW) Non Operating Income (2019 - 2025)
Celularity (CELUW) reported Non Operating Income of -$2.3 million for Q4 2025, up 83.53% year-over-year from -$1.3 million in Q4 2024, and down 199.22% quarter-over-quarter from -$769000.0 in Q3 2025.
Celularity (CELUW) Non Operating Income (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Non Operating Income data on file, last reported at -$2.3 million in Q4 2025.
- Non Operating Income for Q4 2025 came in at -$2.3 million, up 83.53% year-over-year; the trailing twelve-month figure through Dec 2025 was -$16.8 million (up 43.15% YoY), and the FY2025 annual result was -$30.4 million, down 55.65% from the prior year.
- Non Operating Income slipped to -$2.3 million in Q4 2025 per CELUW's latest filing, from -$769000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $122.5 million in Q4 2023 and troughed at -$14.6 million in Q1 2024.
- A 5-year average of $5.4 million and a median of -$605000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income soared 13246.88% in 2022, then slumped 3219.05% in 2024.
- A 5-year view of Non Operating Income shows it stood at $288000.0 in 2021, then soared by 13246.88% to $38.4 million in 2022, then surged by 218.76% to $122.5 million in 2023, then sank by 111.4% to -$14.0 million in 2024, then surged by 83.53% to -$2.3 million in 2025.
- Business Quant data shows CELUW's Non Operating Income at -$2.3 million in Q4 2025, -$769000.0 in Q3 2025, and -$4.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Celularity | - | - | -3.27 Mn | -2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | -769,000.00 |
| Jun 30, 2025 | -4.43 Mn |
| Mar 31, 2025 | -9.27 Mn |
| Dec 31, 2024 | -13.97 Mn |
| Sep 30, 2024 | -4.57 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | -14.64 Mn |
| Dec 31, 2023 | 122.53 Mn |
| Sep 30, 2023 | -862,000.00 |
| Jun 30, 2023 | -5.47 Mn |
| Mar 31, 2023 | -441,000.00 |
| Dec 31, 2022 | 38.44 Mn |
| Sep 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 415,000.00 |
| Mar 31, 2022 | -327,000.00 |
| Dec 31, 2021 | 288,000.00 |
| Sep 30, 2021 | -109,000.00 |
| Jun 30, 2021 | -2.00 Mn |
| Mar 31, 2021 | -27,000.00 |